04/20/20
RUTGERS, UNIVERSITY HOSPITAL LEAD WAY IN TREATING COVID-19 WITH CONVALESCENT PLASMA FROM RECOVERED PATIENTS
Researchers, doctors call for more blood donations from former patients to help treat critically ill
Rutgers physicians and University Hospital are leading the way in using blood plasma from patients who recovered from COVID-19 to treat new patients who are severely ill with COVID-19 infections. The clinicians and hospital are calling for more blood donations from those who have survived the deadly infection.
Although COVID-19 infections and fatalities continue to increase in New Jersey and across the United States, more than 50,000 people have recovered from the novel virus. Their blood plasma
contains antibodies that may help critically ill patients fight, and perhaps conquer, the virus.
Last Friday, Rutgers practitioners at University Hospital received the first FDA approval for this treatment in New Jersey, and have thus far treated 17 patients with convalescent plasma. FDA
approval is pending for the use of this treatment for additional patients.
The effectiveness of this treatment is not yet known, though similar treatment has been studied for Ebola and the MERS virus. Practitioners and researchers will monitor and investigate the progress of COVID-19 patients who receive this treatment.
“The use of convalescent plasma – blood plasma from individuals who have recovered from COVID-19 – presents real hope for saving lives,” said Marc Klapholz, Chair of the Department of Medicine at Rutgers New Jersey Medical School and University Hospital, and the Principal Investigator for the use of Convalescent COVID-19 plasma.
“In our battle against the COVID-19 virus, we are excited to be trialing this potential life-saving therapy in partnership with Rutgers New Jersey Medical School. This treatment plan has been
used for more than 100 years to address disease outbreaks for other conditions, and we’re optimistic that it will save lives,” said Shereef Elnahal, President and CEO of University Hospital.
People interested in donating plasma must have had a confirmed positive test for COVID-19 from a lab or health facility and be eligible to donate blood. They can reach the Rutgers and
University Hospital COVID-19 Treatment Group at 973-972-5474 or via email at covidplasma@uhnj.org.
UNIVERSITY HOSPITAL EMS FIRST IN UNITED STATES TO RECEIVE LANDMARK ACCREDITATION FOR PRE-HOSPITAL BLOOD TRANSFUSION PROGRAM
June 17, 2026: University Hospital announced today that it has become the first emergency medical service (EMS) program in the United States to receive formal accreditation from the Association for the Advancement of Blood & Biotherapies (AABB) for its pre-hospital blood transfusion program, marking a major milestone in advancing emergency medical care and improving patient […]
Newark Community Leaders, Health Care and Public Safety Experts Join University Hospital Board of Directors
NEWARK, N.J. — University Hospital, the State’s only public academic medical center, the principle teaching hospital for Rutgers New Jersey Medical School and the Rutgers School of Dental Medicine, and the sole state-certified Level I Trauma Center in Northern New Jersey, today announced that the New Jersey State Senate has approved five new members to […]
Newark’s University Hospital is Highest-Ranked NJ Hospital on Forbes’ 2026 America’s Best Midsize Employers List
February 17, 2026, NEWARK: University Hospital in Newark, New Jersey has been recognized by Forbes as one of America’s Best Midsize Employers for 2026. Employers are recognized for their employee satisfaction and their commitment to fostering a strong positive workplace culture. University Hospital is the highest-ranked healthcare institutions in New Jersey on the list and […]